Assignee
NANJING TRANSTHERA BIOSCIENCES CO LTD
CN·7 granted patents·5 pending applications·10 citations·filing 2017–2021
Top patents by PatentIndex Score
12 records- 0189US10208042B1Multi-kinase inhibitor compound, and crystal form and use thereofNANJING TRANSTHERA BIOSCIENCES CO LTD·Filed 2018·Granted Feb 19, 2019·3 cites·2 claims
- 0287US11649233B2Halo-allylamine SSAO/VAP-1 inhibitor and use thereofNANJING TRANSTHERA BIOSCIENCES CO LTD·Filed 2018·Granted May 16, 2023·4 cites·11 claims
- 0384US10889591B2PDE9 inhibitor and use thereofNANJING TRANSTHERA BIOSCIENCES CO LTD·Filed 2019·Granted Jan 12, 2021·2 cites·8 claims
- 0478US10889586B2Multi-kinase inhibitor compound, and crystal form and use thereofNANJING TRANSTHERA BIOSCIENCES CO LTD·Filed 2019·Granted Jan 12, 2021·1 cites·20 claims
- 0560US11434248B2PDE9 inhibitor and use thereofNANJING TRANSTHERA BIOSCIENCES CO LTD·Filed 2021·Granted Sep 6, 2022·0 cites·19 claims
- 0646US11046679B2Indoleamine 2,3-dioxygenase inhibitor and applicationNANJING TRANSTHERA BIOSCIENCES CO LTD·Filed 2018·Granted Jun 29, 2021·0 cites·20 claims
- 0746US2022073496A1Novel quinoline derivative inhibitorNANJING TRANSTHERA BIOSCIENCES CO LTD·Filed 2019·Application pending·0 cites
- 0844US2022081409A1Pde9 inhibitor and use thereofNANJING TRANSTHERA BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 0944US2020407370A1Peptidylarginine deiminase inhibitor and use thereofNANJING TRANSTHERA BIOSCIENCES CO LTD·Filed 2019·Application pending·0 cites
- 1043US2020361919A1Deuterated indoleamine 2,3-dioxygenase inhibitor and application thereofNANJING TRANSTHERA BIOSCIENCES CO LTD·Filed 2018·Application pending·0 cites
- 1140US10744139B2Inhibitors of fibroblast growth factor receptor and use thereofNANJING TRANSTHERA BIOSCIENCES CO LTD·Filed 2017·Granted Aug 18, 2020·0 cites·19 claims
- 1240US2021177828A1Tam family kinase /and csf1r kinase inhibitor and use thereofNANJING TRANSTHERA BIOSCIENCES CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NANJING TRANSTHERA BIOSCIENCES CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →